News

Argentx's Upcoming Investor Events Highlight Progress in Immunology

Argentx's Upcoming Investor Events Highlight Progress in Immunology

Upcoming Investor Conferences

Argentx (NASDAQ: ARGX), a leader in immunology focused on enhancing the quality of life for those battling severe autoimmune conditions, is gearing up for a couple of prominent investor conferences this coming September. These events not only illustrate the company's commitment to innovation but also provide a platform for sharing insights and developments with interested investors.

Wells Fargo Healthcare Conference

The first of these events is the 2025 Wells Fargo Healthcare Conference, where the management team of argentx will engage in a constructive fireside chat on Thursday, September 4, 2025, at 8:00 a.m. ET. This venue will provide an opportunity to discuss both present initiatives and future aspirations in the realm of healthcare.

Morgan Stanley Global Healthcare Conference

Following that, argentx will participate in the Morgan Stanley 23rd Annual Global Healthcare Conference. This presentation is scheduled for Monday, September 8, 2025, at 7:00 a.m. ET. Such gatherings are pivotal for networking and for showcasing the innovations in biomedical research that argentx has been pioneering.

Live Streaming and Presentation Access

Investors who are unable to attend these events in person will have access to a live webcast through the Investors section of the argentx website. Following the events, replays of the presentations will be available for viewing on the website for approximately 30 days, ensuring that stakeholders can stay informed regarding the latest organizational updates.

About Argentx

Argentx is dedicated to transforming the treatment landscape for individuals suffering from serious autoimmune diseases. The company collaborates with distinguished researchers through its Immunology Innovation Program (IIP), aiming to translate groundbreaking immunology findings into a diverse portfolio of innovative antibody-based therapies. Argentx is notably working on the first clinically approved neonatal Fc receptor (FcRn) blocker and is exploring its vast potential in treating various severe autoimmune disorders.

Contact Information

For media inquiries, contact Ben Petok at bpetok@argenx.com. For investor relations, reach out to Alexandra Roy at aroy@argenx.com.

Frequently Asked Questions

What is the significance of the upcoming investor conferences for argentx?

These conferences are essential for argentx to showcase its research advancements and engage with the investment community.

When are the designated conferences occurring?

The Wells Fargo Healthcare Conference is on September 4, 2025, and the Morgan Stanley conference is on September 8, 2025.

How can I access the presentations?

Live webcasts of the presentations can be accessed through the argentx website, with replays available for 30 days post-event.

What areas of immune therapy does argentx focus on?

Argentx primarily targets serious autoimmune diseases with its innovative antibody-based therapies.

Who should be contacted for media inquiries regarding argentx?

Media inquiries should be directed to Ben Petok via email.

About The Author

About Investors Hangout

Investors Hangout is a leading online stock forum for financial discussion and learning, offering a wide range of free tools and resources. It draws in traders of all levels, who exchange market knowledge, investigate trading tactics, and keep an eye on industry developments in real time. Featuring financial articles, stock message boards, quotes, charts, company profiles, and live news updates. Through cooperative learning and a wealth of informational resources, it helps users from novices creating their first portfolios to experts honing their techniques. Join Investors Hangout today: https://investorshangout.com/

The content of this article is based on factual, publicly available information and does not represent legal, financial, or investment advice. Investors Hangout does not offer financial advice, and the author is not a licensed financial advisor. Consult a qualified advisor before making any financial or investment decisions based on this article. This article should not be considered advice to purchase, sell, or hold any securities or other investments. If any of the material provided here is inaccurate, please contact us for corrections.

Top 10 Most Recent News Articles

CureGene's Evategrel Aims for Breakthrough in Stroke Care

Updated Category News Views 172

Revolutionizing Stroke Care: Enter Evategrel When it comes to strokes, time is money—and I'm telling you, this ain't an area where you can afford to twiddle your thumbs. The faster you can get that blood flowing again, the better the chance you've got of walking away with less damage. That's where CureGene's new investigational drug, Evategrel, comes in. Why Evategrel...

Continue Reading
Xiaomi's Smart Auto Factory Draws Global Media Praise

Updated Category News Views 178

Xiaomi Impresses Global Media in Beijing Factory Tour In the ever-changing world of NEVs (New Energy Vehicles), a tour of Xiaomi's smart auto factory in Beijing has made waves among global media folks. These scribes got an up-close look at Xiaomi's magic mix of tech and style on November 6, part of a grand media gathering. What's Under the Hood? Marcos Costa de Oliveira,...

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 228

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading
Niagara Networks Boosts TLS 1.3 Decryption to 90+ Gbps

Updated Category News Views 73

In a digital era where encryption is racing ahead like a runaway train, Niagara Networks has stepped up with some serious muscle enhancements to their ePacketron platform. They're not just playing catch-up with the latest TLS 1.3 decryption capabilities; they're leading the charge with a robust over 90 Gbps performance—no small feat in today's encrypted traffic...

Continue Reading
AWS Boosts Agilix's AI Education in Sierra Leone

Updated Category News Views 21

Agilix Labs' Landmark Leap with AWS Just when you think you've got the grip on global education dynamics, a new wave hits your shores, this time courtesy of Agilix Labs and AWS. Agilix Labs snagged a grant from Amazon Web Services, carving a path that blends AI with educational equity in Sierra Leone. Now, if that doesn’t prick up investor ears or yank a few...

Continue Reading
Segway Powersports Ventures into Baja 1000: Ambitions Run High

Updated Category News Views 124

They're gunning for glory in the sands of Baja, folks—Segway Powersports is about to rev up the excitement with its Baja 1000 debut. Never heard before in this legendary race's chronicles, Segway aims to shake up the game with their two brawny Super Villain UTVs. These aren't your run-of-the-pavement ride-ons; they're built for the rough stuff—and if there's a stage...

Continue Reading
Antengene’s AnTenGager-D2 Advances in Cancer Treatment

Updated Category News Views 119

Antengene's AnTenGager-D2 Offers Fresh Hope Alright, let's dig into the latest buzz from the 2026 Society for Immunotherapy of Cancer conference about Antengene's AnTenGager-D2 platform. If you're not into biotech lingo, buckle up, because this is a ride into the future of cancer treatments—where science fiction might soon become science fact. A Novel Approach to Tumor...

Continue Reading
Ericsson Buybacks: Strategic Moves or Market Maneuver?

Updated Category News Views 10

Breaking Down Ericsson's Strategic Share Buybacks When a company like Ericsson starts pulling stocks off the shelves like they're on sale, it's time to take notice. Between November 2nd and 6th, Ericsson, that telecom giant we all know, went on a little shopping spree, snapping up 500,000 of its own Class B shares. Why should we care? Well, it's a part of their hefty SEK...

Continue Reading
Inside Kristallnacht: An XR Journey for a New World

Updated Category News Views 67

Bridging the Past with Powerful Tech: A Journey to Kristallnacht Let's cut to the chase: if there's a time in history that we all need to sear into our collective consciousness, it's Kristallnacht. Forget the mere notion of reading it from a textbook; now you can dive headfirst into the harrowing events of November 9, 1938, thanks to the cutting-edge initiative inside...

Continue Reading
D-Wave's Legal Trouble: Securities Fraud Suit Looms

Updated Category News Views 481

A Looming Legal Storm for D-Wave Investors Call it another day, another legal tangle in the investing world. This time, it's D-Wave Quantum Inc. (NASDAQ: QBTS) on the receiving end of a securities fraud class action lawsuit. Yeah, those fancy quantum computers they're pushing didn't predict this one coming. The legal arena is getting ready for a bout, and if you've got...

Continue Reading

Top 5 Most Recently Viewed Articles

Critical Metals Corp Unveils Impressive Rare Earth Findings

Updated Category News Views 93

Exciting Discoveries from the Tanbreez Project Critical Metals Corp, a prominent player in mining development, recently announced the remarkable results of its 2024 drilling program at the Tanbreez Rare Earth Project. These findings emphasize the continuous mineralization of rare earth elements, underlining the project's promising potential. The results highlight key...

Continue Reading
Silver Star Properties REIT Addresses Shareholder Concerns

Updated Category News Views 202

Silver Star Properties REIT Responds to Former CEO's Claims In a significant move to maintain transparency, Silver Star Properties REIT, Inc. has addressed recent statements from its former CEO, Al Hartman. The company, focused on repositioning itself within the self-storage asset class, is dedicated to ensuring its shareholders have access to accurate information amidst...

Continue Reading
Atico Mining Restructures Credit Facility with Trafigura

Updated Category News Views 352

Atico Mining Partners with Trafigura on Credit Restructuring VANCOUVER, British Columbia – Atico Mining Corporation (the “Company” or “Atico”) (TSX.V: ATY | OTC: ATCMF) has made significant strides towards financial stability by entering into a term sheet with Trafigura PTE. LTD. This agreement represents an essential amendment and extension of Atico's existing...

Continue Reading
Walmart Embraces AI Revolution in Retail Operations

Updated Category News Views 153

AI Transformation at Walmart In today's rapidly evolving world, no job can claim to be untouchable, including those involved in tasks like retrieving shopping carts from parking lots. This stark reality was articulated by Walmart's CEO Doug McMillon during a recent event. He emphasized that the introduction of artificial intelligence (AI) will impact every role at...

Continue Reading
Family RV Association Welcomes Doug Uhlenbrock as New Leader

Updated Category News Views 232

Family RV Association Announces Executive Director Appointment CINCINNATI – Doug Uhlenbrock, who has dedicated 24 years of his career to the Family RV Association, has been appointed as the new executive director of the organization. This decision comes after the Executive Board unanimously supported his transition into this significant leadership position. Experience...

Continue Reading